Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam Cohort studies

Journal of Clinical Microbiology

Volumn 36, Issue 10, 1998, Pages 3002-3006

  Beld, Marcel ^a   Penning, Maarten ^a   Van Putten, Marieke ^a   Van Den Hoek, Anneke ^b   Lukashov, Vladimir ^a   McMorrow, Martin ^b   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; NETHERLANDS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROCONVERSION; SEROTYPE; VIRUS ISOLATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031709804     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.10.3002-3006.1998     Document Type: Article

References (18)

1. Aiyama, T., K. Yoshioka, H. Hirofuji, A. Kusakabe, M. Yamada, K. Tanaka, and S. Kakumu. 1994. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 39:2244-2249.
2. Beld, M., M. Penning, M. McMorrow, J. Gorgels, A. van de Hoek, and J. Goudsmit. 1998. Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J. Clin. Microbiol. 36:872-877.
3. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89:4942-4946.
4. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Oberby, D. W. Bradley, and M. Houghton. 1989. Isolation of cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science 244:359-362.
5. Dixit, V., S. Quan, P. Martin, M. Brezina, R. DiNello, K. Sra, J. Y. N. Lau, D. Chien, J. Kolberg, A. Tagger, G. Davis, A. Polito, and G. Gitnick. 1995. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J. Clin. Microbiol. 33:2978-2183.
6. Dusheiko, G., H. Schmilovitz-Weiss, D. Brown, F. McOmish, P. Yap, S. Sherlock, N. McIntyre, and P. Simmonds. 1994. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
7. Köhler, H., J. Goudsmit, and P. Nara. 1992. Clonal distance: cause for a limited and failing immune response to HIV-1 infection and vaccination. J. Acquired Immune Defic. Syndr. 5:1158-1168.
8. Köhler, H., S. Müller, and P. Nara. 1994. Deceptive imprinting in the immune response against HIV-1. Immunol. Today 15:455-501.
9. Lang, T. A., and M. Secic. 1997. Determing the presence or absence of disease, p. 147-169. In E. J. Huth (ed.), How to report statistics in medicine. BMJ Publishing Group, Philadelphia, Pa.
10. León, P., J. A. López, C. Elola, S. Quan, and J. M. Echevarria. 1997. Typing of hepatitis C virus antibody with specific peptides in seropositive blood donors and comparison with genotyping of viral RNA. Vox Sang. 72:71-75.
11. McOmish, F., S. W. Chan, B. C. Dow, J. Gillon, W. D. Frame, R. J. Crawford, P. L. Yap, E. A. Follett, and P. Simmonds. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13.
12. Pawlotsky, J. M., L. Tsakiris, F. Roudot-Thoraval, C. Pellet, L. Stuyver, J. Duval, and D. Dhumeaux. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. Infect. Dis. 171:1607-1610.
13. Simmonds, P., E. C. Holmes, T. A. Cha, S. W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399.
14. Simmonds, P., F. McOmish, P. L. Yap, S. W. Chan, C. K. Lin, G. Dusheiko, A. A. Saeed, and E. C. Holmes. 1993. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 74:661-668.
15. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74: 1093-1102.
16. Takada, N., S. Takase, N. Enomoto, A. Takada, and T. Date. 1992. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J. Hepatol. 14:35-40.
17. Tsubota, A., K. Chayama, K. Ikeda, A. Yasuji, I. Koida, S. Saitoh, M. Hashimoto, S. Iwasaki, M. Kobayashi, and K. Hiromitsu. 1994. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
18. van den Hoek, J. A. R., R. A. Coutinho, H. J. van Haastrecht, A. W. van Zadelhoff, and J. Goudsmit. 1988. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 2: 55-60.